Shattuck Labs Inc
STTK
ISIN US82024L1035 / Valor 57260669
Shattuck Labs Inc
UMushroom community rating:
About company
Shattuck Labs Inc. is a biotechnology firm focused on the development of innovative immunotherapy treatments. The company has built a significant portfolio, comprising over 400 bi-functional fusion proteins. These proteins are designed to target a range of clinically validated and emerging pathways, enabling Shattuck Labs to develop therapies that aim to be both best-in-class and first-in-class. This approach suggests a strategic focus on leveraging cutting-edge science to address unmet medical needs in the field of immunotherapy, positioning the company at the forefront of advancements in treatment methodologies. Through its proprietary technologies and extensive portfolio, Shattuck Labs seeks to make a meaningful impact on patient care in the oncology and autoimmune disease spaces.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
126 M
Market cap (USD)
56,546
Daily traded volume (Shares)
1.13 / 0.9901
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
